home / stock / huge:cc / huge:cc news

HUGE:CC News and Press, Fsd Pharma Inc. Subordinate Voting Shares From 11/17/23

Stock Information
Company Name: Fsd Pharma Inc. Subordinate Voting Shares
Stock Symbol: HUGE:CC
Market: CNQC
Website: fsdpharma.com
Menu
HUGE:CC HUGE:CC Quote HUGE:CC Short HUGE:CC News HUGE:CC Articles HUGE:CC Message Board
Get HUGE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
HUGE:CC - InvestorNewsBreaks - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Releases Date for Planned Distribution of Celly Nu Shares

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has announced the distribution date that its securityholders can expect to receive common shares in the capital of Celly Nutrition Corp. Th...
HUGE:CC - FSD Pharma Announces Distribution Date for Distribution of Celly Shares Pursuant to Plan of Arrangement

TORONTO, ON / ACCESSWIRE / November 17, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that, further to its press releas...

HUGE:CC - Expected Canadian Company Earnings on Friday, November 17th, 2023

Real Matters Inc. (REAL:CA) is expected to report $0 for Q4 2023 South Star Battery Metals Corp. (STS:CA) is expected to report for Q1 2024 Appulse Corporation (APL:CA) is expected to report for Q1 2024 Cascadero Copper Corporation (CCD:CA) is expected to report for quarter end 2023-0...

HUGE:CC - InvestorNewsBreaks - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Filing of Supplement to Management Information Circular

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has filed a supplement related to certain restrictions on resale that will apply to the Celly Nu shares that will be distributed to the FSD...
HUGE:CC - FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023

TORONTO, ON / ACCESSWIRE / November 15, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions,is pleased to announce that it has provided certain addit...

HUGE:CC - Expected Canadian Company Earnings on Friday, November 10th, 2023

Resverlogix Corp. (RVX:CA) is expected to report for Q1 2024 SNC-Lavalin Group Inc. (ATRL:CA) is expected to report $0.37 for Q3 2023 Cascadero Copper Corporation (CCD:CA) is expected to report for quarter end 2023-08-31 Pivotree Inc. (PVT:CA) is expected to report $-0.03 for Q3 2023 ...

HUGE:CC - Expected earnings - FSD Pharma Inc Subordinate Voting Shares

FSD Pharma Inc Subordinate Voting Shares (HUGE:CNX) is expected to report for Q3 2023
HUGE:CC - InvestorNewsBreaks - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Releases Status Update on Proposed Celly Nu Dividend Distribution

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, will soon be announcing the record date for the company's special dividend of shares of Celly Nutrition Corp. According to the announcement...

HUGE:CC - FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basis

TORONTO, ON / ACCESSWIRE / November 7, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions,is pleased to announce that the company, in the upcoming w...

HUGE:CC - FSD Pharma Files Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus

TORONTO, ON / ACCESSWIRE / November 6, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (" FSD Pharma " or the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that in order to replace its prior...
Previous 10 Next 10